Bulletin

WHO

First phase of polio campaign concludes successfully in Gaza

September 4, 2024

WHO

New global guidance aims to curb antibiotic pollution from manufacturing

September 3, 2024

Roche

Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH

August 27, 2024

WHO

Sudan conflict and refugee crisis, Multi-country External Situation Report #3, covering the reporting period July 2024

August 23, 2024

WHO

Disease Outbreak News : Mpox – African Region

August 22, 2024

Roche

Roche responds to WHO’s declaration of a global health emergency due to the ongoing mpox outbreak

August 20, 2024

Press Information Bureau

Prime Minister Shri Narendra Modi continues to monitor the MPox situation in view of its declaration as a Public Health Emergency of International Concern by WHO

August 18, 2024

Press Information Bureau

Union Health Ministry assures Doctors of all possible efforts to ensure safety

August 17, 2024

Press Information Bureau

Union Minister of Health & Family Welfare Shri JP Nadda reviews the Monkeypox situation and preparedness

August 17, 2024

WHO

Multi-country outbreak of cholera, External situation report #17

August 15, 2024

Press Information Bureau

On the 77th Independence Day, Prime Minister appreciates nurses, doctors and others for their efforts for changing the fortune of the country

August 15, 2024

Press Information Bureau

ICMR and Panacea Biotec initiate the First Dengue Vaccine Phase 3 Clinical Trial in India with Indigenous Dengue Vaccine, DengiAll

August 14, 2024

WHO

WHO invites mpox vaccine manufacturers to submit dossiers for emergency evaluation

August 9, 2024

Press Information Bureau

Steps Taken to Strengthen Mental Healthcare Services

August 9, 2024

Press Information Bureau

Under Pradhan Mantri Bhartiya Janaushadhi Pariyojana only quality medicines are supplied through Jan Aushadhi Kendras

August 9, 2024

Press Information Bureau

32 projects with cumulative installed capacity of 56,679 MT per annum have been completed under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country

August 9, 2024

< 1 … 22 23 24 25 26 27 28 29 30 … 94 >

Maker Towers 63 A ,Cuffe Parade South Mumbai Maharashtra Pin Code 400005

About Us Advisory Board Profile

Announcements Featured Story Highlights Bulletin

Interview Guest Desk Viewpoint

Bulletin

First phase of polio campaign concludes successfully in Gaza

New global guidance aims to curb antibiotic pollution from manufacturing

Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH

Sudan conflict and refugee crisis, Multi-country External Situation Report #3, covering the reporting period July 2024

Disease Outbreak News : Mpox – African Region

Roche responds to WHO’s declaration of a global health emergency due to the ongoing mpox outbreak

Prime Minister Shri Narendra Modi continues to monitor the MPox situation in view of its declaration as a Public Health Emergency of International Concern by WHO

Union Health Ministry assures Doctors of all possible efforts to ensure safety

Union Minister of Health & Family Welfare Shri JP Nadda reviews the Monkeypox situation and preparedness

Multi-country outbreak of cholera, External situation report #17

On the 77th Independence Day, Prime Minister appreciates nurses, doctors and others for their efforts for changing the fortune of the country

ICMR and Panacea Biotec initiate the First Dengue Vaccine Phase 3 Clinical Trial in India with Indigenous Dengue Vaccine, DengiAll

WHO invites mpox vaccine manufacturers to submit dossiers for emergency evaluation

Steps Taken to Strengthen Mental Healthcare Services

Under Pradhan Mantri Bhartiya Janaushadhi Pariyojana only quality medicines are supplied through Jan Aushadhi Kendras

32 projects with cumulative installed capacity of 56,679 MT per annum have been completed under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country

Company

Resources